Improving prevention strategies for cardiometabolic disease. (2020)

First Author: Sattar N
Attributed to:  Stat2 is a therapeutic target in liver inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-020-0786-7

PubMed Identifier: 32152584

Publication URI: http://europepmc.org/abstract/MED/32152584

Type: Journal Article/Review

Volume: 26

Parent Publication: Nature medicine

Issue: 3

ISSN: 1078-8956